Houston-based Empower Pharmacy's drugs raised red flags for FDA and other states, but not Texas

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade. In Texas, it has a near-sterling record.

Exelon reaffirms 2026 adjusted operating EPS of $2.81-$2.91 while advancing a $1B, 500-MW New Jersey battery project

In Q2, Exelon reiterated it is "reaffirming our full year guidance of $2.81 to $2.91 per share," consistent with Q1 when management said it was "affirming our 2026 operating earnings guidance of $2.81 ...